Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations

Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations

Higher accessibility and decreasing costs of next generation sequencing (NGS), availability of commercial kits, and development of dedicated analysis pipelines, have allowed an increasing number of laboratories to adopt this technology for HIV drug resistance (HIVDR) genotyping. Conventional HIVDR g...

Full description

Bibliographic Details
Main Authors: Santiago Ávila-Ríos, Neil Parkin, Ronald Swanstrom, Roger Paredes, Robert Shafer, Hezhao Ji, Rami Kantor
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Viruses
Subjects:
HIV drug resistance
next-generation sequencing
low/medium-income countries
implementation
low-abundance variants
Online Access:https://www.mdpi.com/1999-4915/12/6/617

Internet

https://www.mdpi.com/1999-4915/12/6/617

Similar Items